Cohance Lifesciences Closes Trading Window for Insider Trading

Cohance Lifesciences Ltd has announced the closure of its trading window for designated persons and their immediate relatives, effective July 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will remain shut until 48 hours after the declaration of the company's unaudited financial results (standalone and consolidated) for the quarter ending June 30, 2026. The specific date for the board meeting to approve these results will be communicated later.